Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Meghan Hattarki, Chi‐Yeh Chung et al.|Cell chemical biology|2023Cited by 72
Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcriptionHuawei Wang, Richard Klemke, John D. Lapek et al.|Cell Discovery|2018Cited by 32
Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL LeukemiaShellaina J.V. Gordon, Mark A. Dawson, Florian Perner et al.|Cancer Discovery|2025Cited by 20
LC/LC–MS/MS of an innovative prostate human epithelial cancer (PHEC) in vitro model systemJohn D. Lapek, Alan E. Friedman, James L. McGrath et al.|Journal of Chromatography B|2012Cited by 7
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J.V. Gordon, Mark A. Dawson, Florian Perner et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 5